Milestone Scientific shares surge 40.14% premarket after reporting $500K+ operating expense cuts and stable revenue in Q3 2025.

Milestone Scientific surged 40.14% in premarket trading following the release of its Q3 2025 results, which highlighted a 23% year-over-year improvement in operating loss to $1.1 million and a $500,000 reduction in operating expenses. The company emphasized stable revenue ($2.4 million) and progress in operational transformation, including expanded international dental sales and growing recurring medical disposables revenue. CEO Eric Hines underscored disciplined cost management, operational restructuring, and advancements in CompuFlo® reimbursement strategy, signaling improved margins and long-term value creation. Despite a net loss of $1.2 million, the focus on leaner operations and strategic growth initiatives in dental and medical segments drove the sharp premarket rally.